urea cycle disorders

Showing 1 posts of 1 posts found.

EU flags

Horizon receives European go-ahead for Ravicti

December 2, 2015
Research and Development, Sales and Marketing Horizon Pharma, Ravicti, horizon, orphan drug, rare disease, urea cycle disorders

The European Commission has approved Ravicti for rare urea cycle disorders.  Ravicti, (glycerol phenylbutyrate), is an oral liquid developed by Horizon …

Latest content